![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif)
GM2-KLH vaccine A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) | GM2-KLH ganglioside KLH-conjugated GM2 Ganglioside Vaccine | | ![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) | GM2-KLH | | ![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115075714im_/http://www.cancer.gov/images/spacer.gif) |